Keilaf Omer David 4
4 · Innoviz Technologies Ltd. · Filed May 4, 2026
Research Summary
AI-generated summary of this filing
Innoviz (INVZ) CEO Omer Keilaf Transfers 723,019 Shares
What Happened Omer Keilaf, CEO of Innoviz Technologies Ltd. (INVZ), reported a disposition of 723,019 ordinary shares on 2026-04-30. The shares were transferred at $0.00 per share (no proceeds reported). The filing identifies the transfer as part of a divorce settlement, not an open‑market sale.
Key Details
- Transaction date: April 30, 2026; Form 4 filed May 4, 2026 (appears timely).
- Transaction type/code: "Other acquisition or disposition" (code J) — transfer to former spouse, Ms. Gali Moscovici (per footnote F1).
- Shares transferred: 723,019; reported price: $0.00 (no consideration reported).
- Shares owned after the transaction: not specified in the filing.
- Additional holdings reported by the insider: 1,135,780 RSUs issuable upon vesting (see footnote F2); vesting schedules span grants from Aug 2022 through Aug 2025 with vesting through 2029. Each RSU converts to one ordinary share and vests only if Keilaf remains a service provider. (Footnote F3: no exercise price applies.)
Context
- Transfers under divorce settlements are routine legal/housekeeping events and do not necessarily reflect the insider’s view of the company’s prospects. This was not an open‑market sale or purchase.
- The large pool of unvested RSUs means Keilaf has potential future stock exposure, subject to continued service and the specified vesting schedules.
Insider Transaction Report
Form 4
Keilaf Omer David
DirectorChief Executive Officer
Transactions
- Other
Ordinary Shares
[F1][F2][F3]2026-04-30−723,019→ 3,505,931 total
Footnotes (3)
- [F1]Represents a transfer of 723,019 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, pursuant to a divorce settlement.
- [F2]The amount includes 1,135,780 ordinary shares issuable upon vesting of restricted share units ("RSUs"); of which (a) 15,596 RSUs granted August 9, 2022, vesting in equal quarterly installments through 2026; (b) 36,630 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 74,008 RSUs granted February 27, 2024, with 14,232 vesting quarterly through 2027 and 59,776 vesting quarterly through 2028; (d) 60,590 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 82,092 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 750,000 RSUs granted May 26, 2025, one-fourth vesting on May 26, 2026, remainder vesting quarterly through 2029; and (g) 116,864 RSUs granted August 5, 2025, one-fourth vesting on August 5, 2026, remainder vesting quarterly through 2029. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.
- [F3]No exercise price is applicable.
Signature
/s/ Dafna Raz - Attorney-in-Fact|2026-05-04